Our purpose was to explore the value of 68Ga-prostate-specific membrane antigen (PSMA)
PET/CT for detection of phosphatase and tensin homolog (PTEN)–loss prostate cancer …

68Ga-labeled prostate-specific membrane antigen (68Ga-PSMA) PET/CT has a proven role
in staging and restaging of prostate cancer (PCA). The aims of this study were to evaluate …

OBJECTIVE. The objective of our study was to investigate whether phosphatase and tensin
homolog (PTEN) expression is associated with clinicopathologic features and …

Background Prostate-specific membrane antigen (PSMA) PET/CT is a highly regarded
radionuclide imaging modality for prostate cancer (PCa). This study aimed to evaluate the …

Purpose: To analyze 68Ga-PSMA-617 PET/CT or PET/MR and delayed PET/MR images in
patients diagnosed with or suspicion of prostate cancer, and to explore the optimal use of …

68Ga-prostate-specific membrane antigen (PSMA) PET/CT is a promising diagnostic tool for
patients with prostate cancer. Our study evaluates SUVs in benign prostate tissue and …

Purpose The early and accurate diagnosis of locoregional recurrence or metastasis in
prostate cancer (PC) has a significant impact on treatment options. Prostatic-specific …

Background We aimed to evaluate the utility of prostate-specific membrane antigen (PSMA)
PET/CT for the detection of local disease within the prostate. Methods This is a retrospective …

Purpose Prostate-specific membrane antigen (PSMA-) PET has become a promising tool in
staging and restaging of prostate carcinoma (PCa). However, specific primary tumour …

We evaluated the accuracy of PET/CT with 68Ga-PSMA-HBED-CC—a 68Ga-conjugated
ligand of human prostate-specific membrane antigen (PSMA)—to localize cancer in the …